PDB38 REAL-WORLD COMPARISON OF HOSPITALIZATION COSTS FOR HEART FAILURE IN T2DM PATIENTS WITH CARDIOVASCULAR DISEASE TREATED WITH CANAGLIFLOZIN VERSUS OTHER ANTIHYPERGLYCEMIC AGENTS

Autor:	Brahim Bookhart, J. Voelker, M. Durkin, Y.W. Chen, Ozgur Tunceli, Christopher D Pericone
Rok vydání:	2019
Předmět:	Canagliflozin medicine.medical_specialty business.industry Health Policy Internal medicine Heart failure Antihyperglycemic Agents Public Health Environmental and Occupational Health Medicine Disease business medicine.disease medicine.drug
Zdroj:	Value in Health. 22:S146
ISSN:	1098-3015
DOI:	10.1016/j.jval.2019.04.588
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::59b0c51bfb6a59f9d0590664349564b9 https://doi.org/10.1016/j.jval.2019.04.588 Zobrazit plný text záznamu Full Text from ScienceDirect